New Approaches in Risk Assessment for Carcinogens
- 1 June 1986
- journal article
- Published by Wiley in Risk Analysis
- Vol. 6 (2) , 195-201
- https://doi.org/10.1111/j.1539-6924.1986.tb00207.x
Abstract
Methods are needed to improve the ability of biomonitoring and epidemiological studies to identify potential carcinogenic hazards and to quantify human risk. The limitations of pharmacokinetic models can be mitigated by the direct measurement of molecular markers of biologically effective dose of carcinogen. Parallel animal and human studies are recommended as a means of validating these markers.Keywords
This publication has 22 references indexed in Scilit:
- Tracking Exposure to Toxic SubstancesScience, 1984
- The genotoxic/epigenetic distinction: Relevance to cancer policyEnvironmental Research, 1984
- Methylation of the O6Position of Guanine in DNA is the Most Likely Initiating Event in Carcinogenesis by Methylating AgentsCancer Investigation, 1984
- Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutationsNature, 1983
- Implication of Nonlinear Kinetics on Risk Estimation in CarcinogenesisScience, 1983
- Biological monitoring in surveillance of exposure to genotoxicantsAmerican Journal of Industrial Medicine, 1983
- Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7′-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, KenyaCarcinogenesis: Integrative Cancer Research, 1983
- Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causationJournal of Chronic Diseases, 1982
- A pilot project in molecular cancer epidemiology: determination of benzo[a]pyrene — DNA adducts in animal and human tissues by immunoassaysCarcinogenesis: Integrative Cancer Research, 1982
- Benzo( a )pyrene-7,8-dihydrodiol 9,10-Oxide Adenosine and Deoxyadenosine Adducts: Structure and StereochemistryScience, 1979